跳转至内容
Merck
CN

SML0408

羧酰氨基三唑

≥98% (HPLC)

别名:

5-氨基-1-(3,5-二氯-4-(4-氯苯甲酰基)苄基甲基)-1H-1,2,3-三氮唑-4-羧酰胺, CAI, L-651582

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C17H12Cl3N5O2
化学文摘社编号:
分子量:
424.67
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Level

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 10 mg/mL (clear solution)

storage temp.

2-8°C

SMILES string

NC(=O)c1nnn(Cc2cc(Cl)c(c(Cl)c2)C(=O)c3ccc(Cl)cc3)c1N

InChI

1S/C17H12Cl3N5O2/c18-10-3-1-9(2-4-10)15(26)13-11(19)5-8(6-12(13)20)7-25-16(21)14(17(22)27)23-24-25/h1-6H,7,21H2,(H2,22,27)

InChI key

WNRZHQBJSXRYJK-UHFFFAOYSA-N

Biochem/physiol Actions

羧胺三唑(CAI)是一种没有细胞毒性的抗癌药物。它具有抗炎特性,并减少促炎细胞因子的释放。CAI可以在体外体内阻止多种人类癌细胞和内皮细胞的增殖和侵袭行为。它可用于治疗多种急性和慢性炎症模型,如佐剂性关节炎和炎症性肠病(IBD)。CAI在体外阻断肿瘤细胞增殖并刺激细胞凋亡。
羧酰氨基三唑是一种钙通道阻滞剂/钙通量抑制剂;阻断 CRAC 通道功能。
羧酰氨基三唑(L-651582)是一种口服活性钙通道阻滞剂。羧酰氨基三唑阻断细胞内和线粒体钙的进入和通量,从而抑制细胞增殖、激活钙释放激活的钙通道(CRAC)功能并维持线粒体膜电位。


pictograms

Skull and crossbones

signalword

Danger

hcodes

Hazard Classifications

Acute Tox. 3 Oral

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


商品

We offers many products related to calcium channels for your research needs.

我们提供多种与钙通道相关的产品以满足您的各类研究需求。


Fabienne Largey et al.
Neurology(R) neuroimmunology & neuroinflammation, 6(6) (2019-09-27)
To investigate the effects of natalizumab (NAT) treatment on intrathecally produced antiviral antibodies in MS. We performed a longitudinal, observational study analyzing both serum and CSF samples collected before and during NAT treatment for antibodies against measles, rubella, mumps, influenza
Lei Guo et al.
European journal of pharmacology, 746, 14-21 (2014-12-03)
Carboxyamidotriazole (CAI) is a non-cytotoxic anti-tumor drug, which also shows considerable anti-inflammatory effects in a variety of animal models of inflammation. The exact target and mechanism of CAI were not clearly understood yet. In the present study, we demonstrate that
Alessandra Fiorio Pla et al.
Molecular cancer research : MCR, 6(4), 535-545 (2008-04-12)
Growth factor-induced intracellular calcium signals in endothelial cells regulate cytosolic and nuclear events involved in the angiogenic process. Among the intracellular messengers released after proangiogenic stimulation, arachidonic acid (AA) plays a key role and its effects are strictly related to



全球贸易项目编号

货号GTIN
SML0408-5MG04061832962955
SML0408-25MG04061832962948